Williams R - Search Results

1

Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy.

Tang KH, Herrmann E, Cooksley H, Tatman N, Chokshi S, Williams R, Zeuzem S, Naoumov NV. Tang KH, et al. Among authors: williams r. J Hepatol. 2005 Nov;43(5):776-82. doi: 10.1016/j.jhep.2005.05.024. Epub 2005 Jun 28. J Hepatol. 2005. PMID: 16139918

2

Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity.

Rigopoulou EI, Suri D, Chokshi S, Mullerova I, Rice S, Tedder RS, Williams R, Naoumov NV. Rigopoulou EI, et al. Among authors: williams r. Hepatology. 2005 Nov;42(5):1028-36. doi: 10.1002/hep.20888. Hepatology. 2005. PMID: 16250037 Clinical Trial.

3

Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.

Rigopoulou EI, Abbott WG, Williams R, Naoumov NV. Rigopoulou EI, et al. Among authors: williams r. Antiviral Res. 2007 Jul;75(1):36-42. doi: 10.1016/j.antiviral.2006.11.008. Epub 2006 Dec 13. Antiviral Res. 2007. PMID: 17210188

4

Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection.

Riva A, Laird M, Casrouge A, Ambrozaitis A, Williams R, Naoumov NV, Albert ML, Chokshi S. Riva A, et al. Among authors: williams r. Hepatology. 2014 Aug;60(2):487-96. doi: 10.1002/hep.27139. Epub 2014 May 19. Hepatology. 2014. PMID: 24668726 Clinical Trial.

5

Single nucleotide polymorphisms in the interferon-gamma and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus.

Abbott WG, Rigopoulou E, Haigh P, Cooksley H, Mullerova I, Novelli M, Winstanley A, Williams R, Naoumov NV. Abbott WG, et al. Among authors: williams r. Liver Int. 2004 Apr;24(2):90-7. doi: 10.1111/j.1478-3231.2004.00904.x. Liver Int. 2004. PMID: 15078471

6

Managing viral hepatitis.

Tang KH, Williams R. Tang KH, et al. Among authors: williams r. Practitioner. 2003 Jun;247(1647):537-42. Practitioner. 2003. PMID: 12822322 Review. No abstract available.

7

Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.

Hou J, Schilling R, Janssen HL, Hansen BE, Heijtink R, Sablon E, Williams R, Lau GK, Schalm SW, Naoumov NV. Hou J, et al. Among authors: williams r. J Med Virol. 2007 Aug;79(8):1055-63. doi: 10.1002/jmv.20935. J Med Virol. 2007. PMID: 17596838

8

CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.

Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV. Phillips S, et al. Among authors: williams r. J Immunol. 2010 Jan 1;184(1):287-95. doi: 10.4049/jimmunol.0902761. Epub 2009 Nov 30. J Immunol. 2010. PMID: 19949099

9

Identification of serum cytokine profiles associated with HBeAg seroconversion following antiviral treatment interruption.

Chokshi S, Cooksley H, Riva A, Phillips S, Williams R, Gaggar A, Naoumov NV. Chokshi S, et al. Among authors: williams r. Viral Immunol. 2014 Jun;27(5):235-44. doi: 10.1089/vim.2014.0022. Epub 2014 May 5. Viral Immunol. 2014. PMID: 24797262 Clinical Trial.

10

Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.

Lau GK, Suri D, Liang R, Rigopoulou EI, Thomas MG, Mullerova I, Nanji A, Yuen ST, Williams R, Naoumov NV. Lau GK, et al. Among authors: williams r. Gastroenterology. 2002 Mar;122(3):614-24. doi: 10.1053/gast.2002.31887. Gastroenterology. 2002. PMID: 11874993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,949 results

Search Page

Filters